Contract Research Organization WCCT Global Announces Strong Focus on Diabetes Clinical Trials

Share Article

With the rise of Diabetes, WCCT Global is focusing energy on Diabetes clinical trials.

Diabetes Clinical Trials
With the ever rising number of people who are diagnosed with diabetes, we feel compelled to assist in the development of new treatments to help rid this terrible ailment.

WCCT Global, a full-service contract research organization headquartered in Southern California announces today, a strong focus on diabetes research. WCCT Global has been building a patient database for years now and has had a steady flow of possible participants interested in diabetes clinical trials. With this growing data base of diabetic subjects, WCCT Global is now set to quickly recruit in order to have diabetes studies up and running. Along with having a database to be able to recruit from, WCCT Global will also use their highly successful RMT (Recruitment Management Tool). WCCT Global has already been able to identify over 8 million people with diabetes registered to social media accounts.

WCCT Global is capable of recruiting to these populations with the use of the RMT. This will allow for an expedited enrollment process. Talia Nikolao, V.P. of Business Development stated, “With the ever rising number of people who are diagnosed with diabetes, we feel compelled to assist in the development of new treatments to help rid this terrible ailment.” There are over 25 million people in the United States who suffer from diabetes and WCCT Global is striving to be part of the change for the better.

WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work, both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to request information about how WCCT Global can assist your organization with your next clinical study, CLICK HERE.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Talia A. Nikolao, M.B.A.
WCCT Global, LLC
1.714.252.0700 2201
Email >
Follow us on
Visit website